The Ophthalmic Genetics Service at the Casey Eye Institute is one of the premier centers in the world for patients with genetic diseases of the retina and other areas of the eye. Our internationally known doctors have considerable expertise in ophthalmic genetics.
To provide superb patient care, conduct research that will lead to effective treatments for inherited retinal degenerations, and train the next generation of ophthalmic genetics specialists through our ophthalmic genetics fellowship.
The Oregon Retinal Degeneration Center (ORDC) is a core component of the Ophthalmic Genetics Service. This center is supported by the Foundation Fighting Blindness, Inc. to foster the translation of basic science research into useful treatments that can be applied in the clinical setting.
We are pioneering new treatments for retinal diseases. We are currently conducting groundbreaking clinical trials in gene therapy for Stargardt Macular Degeneration, XLRS, Achromatopsia Trials, Usher syndrome type IB neuroprotective factor delivery. If you are interested in participating in a clinical trial, please contact our study coordinator, Maureen McBride, at 503 494-3795.
In addition to clinical research, Casey Eye Institute's molecular diagnostic laboratory plays a major role in identifying new potential gene targets and treatments.